Phase II and Phase III attrition rates 2011–2012 | Nature Reviews Drug Discovery
Nature Reviews Drug Discovery (@NatRevDrugDisc) / Twitter
Target deconvolution strategies in drug discovery | Nature Reviews Drug Discovery
Article series : Nature Reviews Drug Discovery
Volume 21 Issue 7, July 2022
Nature Reviews Drug Discovery - Wikipedia
Volume 18 Issue 6, June 2019
A guide to drug discovery
Pharmacogenetics in drug discovery and development: a translational perspective | Nature Reviews Drug Discovery
Volume 19 Issue 6, June 2020
Volume 19 Issue 11, November 2020
Volume 21 Issue 3, March 2022
The future of drug development: advancing clinical trial design | Nature Reviews Drug Discovery
Screening out irrelevant cell-based models of disease | Nature Reviews Drug Discovery
Volume 14 | Nature Reviews Drug Discovery
Volume 15 | Nature Reviews Drug Discovery
Can the pharmaceutical industry reduce attrition rates? | Nature Reviews Drug Discovery
Volume 20 Issue 4, April 2021
Volume 21 Issue 9, September 2022
Volume 21 Issue 11, November 2022
Predicting in vivo drug interactions from in vitro drug discovery data | Nature Reviews Drug Discovery
Volume 19 | Nature Reviews Drug Discovery
Volume 21 Issue 12, December 2022
THe LOnG pROCeSS OF DRuG DISCOVeRy FROm ORIGInAL IDeA (?) THROuGH THe... | Download Scientific Diagram
Volume 20 Issue 11, November 2021
Molecular imaging in drug development | Nature Reviews Drug Discovery
